HFG Advisors, Inc. Buys 2, Sells 3 in 3rd Quarter

HFG Advisors, Inc. recently filed their 13F report for the third quarter of 2022, which ended on 2022-09-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

7355 E. KEMPER ROAD CINCINATTI, OH 45249

As of the latest 13F report, the guru’s equity portfolio contained 81 stocks valued at a total of $72.00Mil. The top holdings were FV(8.16%), QQQ(7.94%), and VBR(4.47%).

According to GuruFocus data, these were HFG Advisors, Inc.’s top five trades of the quarter.

Vanguard Small Cap Value ETF


During the quarter, HFG Advisors, Inc. bought 5,839 shares of ARCA:VBR for a total holding of 22,432. The trade had a 1.16% impact on the equity portfolio. During the quarter, the stock traded for an average price of $158.1.

On 10/17/2022, Vanguard Small Cap Value ETF traded for a price of $151.4399 per share and a market cap of $22.15Bil. The stock has returned -12.38% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, Vanguard Small Cap Value ETF has a price-earnings ratio of 10.76 and a price-book ratio of 1.79.

CVS Health Corp


The guru sold out of their 6,426-share investment in NYSE:CVS. Previously, the stock had a 0.8% weight in the equity portfolio. Shares traded for an average price of $98.99 during the quarter.

On 10/17/2022, CVS Health Corp traded for a price of $90.78 per share and a market cap of $118.82Bil. The stock has returned 7.95% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, CVS Health Corp has a price-earnings ratio of 14.71, a price-book ratio of 1.58, a price-earnings-to-growth (PEG) ratio of 2.83, a EV-to-Ebitda ratio of 10.19 and a price-sales ratio of 0.39.

The price-to-GF Value ratio is 1.04, earning the stock a GF Value rank of 3.

First Trust NASDAQ Rising Dividend Achievers ETF


HFG Advisors, Inc. reduced their investment in NAS:RDVY by 11,371 shares. The trade had a 0.63% impact on the equity portfolio. During the quarter, the stock traded for an average price of $42.79.

On 10/17/2022, First Trust NASDAQ Rising Dividend Achievers ETF traded for a price of $40.545 per share and a market cap of $7.54Bil. The stock has returned -17.25% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, First Trust NASDAQ Rising Dividend Achievers ETF has a price-earnings ratio of 9.67 and a price-book ratio of 1.99.

Procter & Gamble Co


HFG Advisors, Inc. reduced their investment in NYSE:PG by 2,606 shares. The trade had a 0.51% impact on the equity portfolio. During the quarter, the stock traded for an average price of $142.05.

On 10/17/2022, Procter & Gamble Co traded for a price of $127.96 per share and a market cap of $305.03Bil. The stock has returned -8.99% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Procter & Gamble Co has a price-earnings ratio of 22.01, a price-book ratio of 6.69, a price-earnings-to-growth (PEG) ratio of 2.42, a EV-to-Ebitda ratio of 15.59 and a price-sales ratio of 4.04.

The price-to-GF Value ratio is 0.85, earning the stock a GF Value rank of 7.

FIRST TR EXCH TRD


During the quarter, HFG Advisors, Inc. bought 6,272 shares of NAS:FYC for a total holding of 16,934. The trade had a 0.47% impact on the equity portfolio. During the quarter, the stock traded for an average price of $58.79.

On 10/17/2022, FIRST TR EXCH TRD traded for a price of $55.4768 per share and a market cap of $196.94Mil. The stock has returned -23.86% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, FIRST TR EXCH TRD has a price-earnings ratio of 13.03 and a price-book ratio of 2.86.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.